BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 25751257)

  • 21. Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells.
    Otoshi T; Tanaka T; Morimoto K; Nakatani T
    PLoS One; 2015; 10(12):e0145769. PubMed ID: 26713736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
    Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
    Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
    Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y
    Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
    Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
    BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
    Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
    Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway.
    Zhang G; Yu Z; Fu S; Lv C; Dong Q; Fu C; Kong C; Zeng Y
    Cancer Gene Ther; 2019 Sep; 26(9-10):323-333. PubMed ID: 30459398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
    Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
    Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of ETS2 inhibits the invasion and metastasis of renal cell carcinoma cells by inducing EMT via the PI3K/Akt signaling pathway.
    Zhang GW; Tian X; Li Y; Wang ZQ; Li XD; Zhu CY
    Biomed Pharmacother; 2018 Aug; 104():119-126. PubMed ID: 29772431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas.
    Mikami S; Mizuno R; Kosaka T; Saya H; Oya M; Okada Y
    Int J Cancer; 2015 Apr; 136(7):1504-14. PubMed ID: 25123505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.
    Zhang GM; Luo L; Ding XM; Dong DH; Li B; Ma XC; Sun LJ
    Mol Med Rep; 2016 Jun; 13(6):5029-2036. PubMed ID: 27108693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma.
    Wu DS; Chen C; Wu ZJ; Liu B; Gao L; Yang Q; Chen W; Chen JM; Bao Y; Qu L; Wang LH
    J Exp Clin Cancer Res; 2016 Jul; 35(1):108. PubMed ID: 27377902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-27a promotes cell proliferation and metastasis in renal cell carcinoma.
    Peng H; Wang X; Zhang P; Sun T; Ren X; Xia Z
    Int J Clin Exp Pathol; 2015; 8(2):2259-66. PubMed ID: 25973137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WWOX protein expression varies among RCC histotypes and downregulation of WWOX protein correlates with less-favorable prognosis in clear RCC.
    Lin JT; Tzai TS; Liao CY; Wang JS; Wu TT; Wang HY; Wu CH; Yu CC; Lu PJ
    Ann Surg Oncol; 2013 Jan; 20(1):193-9. PubMed ID: 22555346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of FSTL3 abates the proliferation and metastasis of renal cell carcinoma via the GSK-3β/β-catenin signaling pathway.
    Sun F; Sun P; Yang X; Hu L; Gao J; Tian T
    Aging (Albany NY); 2021 Sep; 13(18):22528-22543. PubMed ID: 34555811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression.
    Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):39-52. PubMed ID: 28993942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of the long non-coding RNA HEIRCC promotes Renal Cell Carcinoma metastasis by inducing epithelial-mesenchymal transition.
    Xiong J; Liu Y; Luo S; Jiang L; Zeng Y; Chen Z; Shi X; Lv B; Tang W
    Oncotarget; 2017 Jan; 8(4):6555-6563. PubMed ID: 28030807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-720 Regulates E-cadherin-αE-catenin Complex and Promotes Renal Cell Carcinoma.
    Bhat NS; Colden M; Dar AA; Saini S; Arora P; Shahryari V; Yamamura S; Tanaka Y; Kato T; Majid S; Dahiya R
    Mol Cancer Ther; 2017 Dec; 16(12):2840-2848. PubMed ID: 28802251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
    Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.